Rab25 in cancer: A brief update

Biochemical Society Transactions

Volumn 40, Issue 6, 2012, Pages 1404-1408

  Mitra, Shreya ^a   Cheng, Kwai W ^a   Mills, Gordon B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer; Endocytosis; Endosomal recycling; Integrin; Rab11a; Rab25

Indexed keywords

CADHERIN; INTEGRIN; PROTEIN RAB25; RAB PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER CELL; CANCER INVASION; CANCER SCREENING; CELL ENERGY; CELL GROWTH; CELL METABOLISM; CELL MIGRATION; COLON CARCINOMA; CONFERENCE PAPER; ENDOMETRIUM CANCER; HUMAN; LYMPH NODE METASTASIS; NEOPLASM; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAB25 GENE; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; DISEASE PROGRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASMS; ONCOGENES; PROTEIN TRANSPORT; RAB GTP-BINDING PROTEINS;

EID: 84870203202     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20120249     Document Type: Conference Paper

References (45)

1. Goldenring, J.R., Shen, K.R., Vaughan, H.D. and Modlin, I.M. (1993) Identification of a small GTP-binding protein, Rab25, expressed in the gastrointestinal mucosa, kidney, and lung. J. Biol. Chem. 268, 18419-18422 (Pubitemid 23273765)
2. Calhoun, B.C. and Goldenring, J.R. (1997) Two Rab proteins, vesicle-associated membrane protein 2 (VAMP-2) and secretory carrier membrane proteins (SCAMPs), are present on immunoisolated parietal cell tubulovesicles. Biochem. J. 325, 559-564 (Pubitemid 27338741)
3. Casanova, J.E., Wang, X., Kumar, R., Bhartur, S.G., Navarre, J., Woodrum, J.E., Altschuler, Y., Ray, G.S. and Goldenring, J.R. (1999) Association of Rab25 and Rab11a with the apical recycling system of polarized Madin-Darby canine kidney cells. Mol. Biol. Cell 10, 47-61 (Pubitemid 29156926)
4. Wang, X., Kumar, R., Navarre, J., Casanova, J.E. and Goldenring, J.R. (2000) Regulation of vesicle trafficking in Madin-Darby canine kidney cells by Rab11a and Rab25. J. Biol. Chem. 275, 29138-29146
5. Goldenring, J.R., Aron, L.M., Lapierre, L.A., Navarre, J. and Casanova, J.E. (2001) Expression and properties of Rab25 in polarized Madin-Darby canine kidney cells. Methods Enzymol. 329, 225-234 (Pubitemid 32107576)
6. Agarwal, R., Jurisica, I., Mills, G.B. and Cheng, K.W. (2009) The emerging role of the RAB25 small GTPase in cancer. Traffic 10, 1561-1568
7. Mills, G.B., Jurisica, I., Yarden, Y. and Norman, J.C. (2009) Genomic amplicons target vesicle recycling in breast cancer. J. Clin. Invest. 119, 2123-2127
8. Tang, B.L. (2010) Is Rab25 a tumor promoter or suppressor: context dependency on RCP status? Tumour Biol. 31, 359-361
9. Mitra, S., Cheng, K.W. and Mills, G.B. (2011) Rab GTPases implicated in inherited and acquired disorders. Semin. Cell Dev. Biol. 22, 57-68
10. He, H., Dai, F., Yu, L., She, X., Zhao, Y., Jiang, J., Chen, X. and Zhao, S. (2002) Identification and characterization of nine novel human small GTPases showing variable expressions in liver cancer tissues. Gene Expression 10, 231-242 (Pubitemid 35315385)
11. Cheng, K.W., Lahad, J.P., Kuo, W.L., Lapuk, A., Yamada, K., Auersperg, N., Liu, J., Smith-McCune, K., Lu, K.H., Fishman, D. et al. (2004) The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat. Med. 10, 1251-1256 (Pubitemid 39540444)
12. Cheng, K.W., Lu, Y. and Mills, G.B. (2005) Assay of Rab25 function in ovarian and breast cancers. Methods Enzymol. 403, 202-215 (Pubitemid 43223113)
13. Fan, Y., Xin, X.Y., Chen, B.L. and Ma, X. (2006) Knockdown of RAB25 expression by RNAi inhibits growth of human epithelial ovarian cancer cells in vitro and in vivo. Pathology 38, 561-567
14. Liu, Y., Tao, X., Jia, L., Cheng, K.W., Lu, Y., Yu, Y. and Feng, Y. (2012) Knockdown of RAB25 promotes autophagy and inhibits cell growth in ovarian cancer cells. Mol. Med. Rep. 6, 1006-1012
15. Davidson, B., Zhang, Z., Kleinberg, L., Li, M., Flørenes, V.A., Wang, T.L. and Shih, I.-M. (2006) Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from diffuse malignant peritoneal mesothelioma. Clin. Cancer Res. 12, 5944-5950 (Pubitemid 44703753)
16. Brusegard, K., Stavnes, H.T., Nymoen, D.A., Flatmark, K., Trope, C.G. and Davidson, B. (2012) Rab25 is overexpressed in Mullerian serous carcinoma compared to malignant mesothelioma. Virchows Arch. 460, 193-202
17. Wrzeszczynski, K.O., Varadan, V., Byrnes, J., Lum, E., Kamalakaran, S., Levine, D.A., Dimitrova, N., Zhang, M.Q. and Lucito, R. (2011) Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer. PLoS ONE 6, e28503
18. Sheach, L.A., Adeney, E.M., Kucukmetin, A., Wilkinson, S.J., Fisher, A.D., Elattar, A., Robson, C.N. and Edmondson, R.J. (2009) Androgen-related expression of G-proteins in ovarian cancer. Br. J. Cancer 101, 498-503
19. Cheng, J.M., Ding, M., Aribi, A., Shah, P. and Rao, K. (2006) Loss of RAB25 expression in breast cancer. Int. J. Cancer 118, 2957-2964
20. Cheng, J.M., Volk, L., Janaki, D.K., Vyakaranam, S., Ran, S. and Rao, K.A. (2010) Tumor suppressor function of Rab25 in triple-negative breast cancer. Int. J. Cancer 126, 2799-2812
21. Yin, Y.X., Shen, F., Pei, H., Ding, Y., Zhao, H., Zhao, M. and Chen, Q. (2012) Increased expression of Rab25 in breast cancer correlates with lymphatic metastasis. Tumour Biol. 33, 1581-1587
22. Kamel, D., Brady, B., Tabchy, A., Mills, G.B. and Hennessy, B. (2012) Proteomic classification of breast cancer. Curr. Drug Targets, doi:CDT-EPUB-20120907-4
23. Prat, A. and Perou, C.M. (2011) Deconstructing the molecular portraits of breast cancer. Mol. Oncol. 5, 5-23
24. Leth-Larsen, R., Terp, M.G., Christensen, A.G., Elias, D., Kühlwein, T., Jensen, O.N., Petersen, O.W. and Ditzel, H.J. (2012) Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis. Mol. Med. 18, 1109-1121
25. Zhang, J., Liu, X., Datta, A., Govindarajan, K., Tam, W.L., Han, J., George, J., Wong, C., Ramnarayanan, K., Phua, T.Y. et al. (2009) RCP is a human breast cancer-promoting gene with Ras-activating function. J. Clin. Invest. 119, 2171-2183
26. Goldenring, J.R. and Nam, K.T. (2011) Rab25 as a tumour suppressor in colon carcinogenesis. Br. J. Cancer 104, 33-36
27. Nam, K.T., Lee, H.J., Smith, J.J., Lapierre, L.A., Kamath, V.P., Chen, X., Aronow, B.J., Yeatman, T.J., Bhartur, S.G., Calhoun, B.C. et al. (2010) Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas. J. Clin. Invest. 120, 840-849
28. Natrajan, R., Williams, R.D., Hing, S.N., Mackay, A., Reis-Filho, J.S., Fenwick, K., Iravani, M., Valgeirsson, H., Grigoriadis, A., Langford, C.F. et al. (2006) Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse. J. Pathol. 210, 49-58 (Pubitemid 44288180)
29. Pärssinen, J., Alarmo, E.L., Karhu, R. and Kallioniemi, A. (2008) PPM1D silencing by RNA interference inhibits proliferation and induces apoptosis in breast cancer cell lines with wild-type p53. Cancer Genet. Cytogenet. 182, 33-39 (Pubitemid 351323965)
30. Pärssinen, J., Alarmo, E.L., Khan, S., Karhu, R., Vihinen, M. and Kallioniemi, A. (2008) Identification of differentially expressed genes after PPM1D silencing in breast cancer. Cancer Lett. 259, 61-70 (Pubitemid 350235092)
31. Bigelow, R.L., Williams, B.J., Carroll, J.L., Daves, L.K. and Cardelli, J.A. (2009) TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro. Breast Cancer Res. Treat. 117, 31-44
32. Simmen, F.A., Su, Y., Xiao, R., Zeng, Z. and Simmen, R.C. (2008) The Krüppel-like factor 9 (KLF9) network in HEC-1-A endometrial carcinoma cells suggests the carcinogenic potential of dys-regulated KLF9 expression. Reprod. Biol. Endocrinol. 6, 41
33. Watanabe, T., Miura, T., Degawa, Y., Fujita, Y., Inoue, M., Kawaguchi, M. and Furihata, C. (2010) Comparison of lung cancer cell lines representing four histopathological subtypes with gene expression profiling using quantitative real-time PCR. Cancer Cell Int. 10, 2
34. Zhang, G., Shang, B., Yang, P., Cao, Z., Pan, Y. and Zhou, Q. (2012) Induced pluripotent stem cell consensus genes: implication for the risk of tumorigenesis and cancers in induced pluripotent stem cell therapy. Stem Cells Dev. 21, 955-964
35. Kessler, D., Gruen, G.C., Heider, D., Morgner, J., Reis, H., Schmid, K.W. and Jendrossek, V. (2012) The action of small GTPases Rab11 and Rab25 in vesicle trafficking during cell migration. Cell. Physiol. Biochem. 29, 647-656
36. Caswell, P.T., Spence, H.J., Parsons, M., White, D.P., Clark, K., Cheng, K.W., Mills, G.B., Humphries, M.J., Messent, A.J., Anderson, K.I. et al. (2007) Rab25 associates withα5β1 integrin to promote invasive migration in 3D microenvironments. Dev. Cell 13, 496-510 (Pubitemid 47514517)
37. Dozynkiewicz, M.A., Jamieson, N.B., Macpherson, I., Grindlay, J., van den Berghe, P.V., von Thun, A., Morton, J.P., Gourley, C., Timpson, P., Nixon, C. et al. (2012) Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression. Dev. Cell 22, 131-145
38. Lapierre, L.A., Caldwell, C.M., Higginbotham, J.N., Avant, K.M., Hall, J., Beauchamp, R.D. and Goldenring, J.R. (2011) Transformation of rat intestinal epithelial cells by overexpression of Rab25 is microtubule dependent. Cytoskeleton 68, 97-111
39. Hanahan, D. and Weinberg, R.A. (2000) The hallmarks of cancer. Cell 100, 57-70 (Pubitemid 30046295)
40. Tong, S.Y., Lee, J.M., Ki, K.D., Choi, Y.J., Seol, H.J., Lee, S.K., Huh, C.Y., Kim, G.Y. and Lim, S.J. (2012) Correlation between FDG uptake by PET/CT and the expressions of glucose transporter type 1 and hexokinase II in cervical cancer. Int. J. Gynecol. Cancer 22, 654-658
41. García Vicente, A.M., Castrejón, Á.S., Relea Calatayud, F., Muñoz, A.P., León Martín, A.A., López-Muñiz, I.C., Del Mar Muñoz Sánchez, M., Cordero García, J.M. and Becerra Nakayo, E.M. (2012) 18F-FDG retention index and biologic prognostic parameters in breast cancer. Clin. Nucl. Med. 37, 460-466
42. Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674
43. Cheng, K.W., Agarwal, R., Mitra, S., Lee, J.S., Carey, M., Gray, J.W. and Mills, G.B. (2012) Rab25 increases cellular ATP and glycogen stores protecting cancer cells from bioenergetic stress. EMBO Mol. Med. 4, 125-141
44. Xue, H., Qiao, Y., Ni, P., Wang, J., Chen, C. and Huang, G. (2011) A CRE that binds CREB and contributes to PKA-dependent regulation of the proximal promoter of human RAB25 gene. Int. J. Biochem. Cell Biol. 43, 348-357
45. No, J.H., Kim, K., Park, K.H. and Kim, Y.B. (2012) Cell-free DNA level as a prognostic biomarker for epithelial ovarian cancer. Anticancer Res. 32, 3467-3471